TY - JOUR
T1 - Mechanism of Ret dysfunction by Hirschsprung mutations affecting its extracellular domain
AU - Iwashita, Toshihide
AU - Murakarni, Hideki
AU - Asai, Naoya
AU - Takahashi, Masahide
N1 - Funding Information:
We are grateful to M. Wada and N. Hasegawa for sequencing of the mutant ret genes, and to M. Ohiwa, T. Kitagawa, K. Imaizumi and J. Aoki for technical assistance. This work was supported in part by grants-in-aid for scientific research and for cancer research from the Ministry of Education, Science and Culture of Japan and by grants from Otsuka Pharmaceutical Co., Ltd and Mitsukoshi Foundation.
PY - 1996/10
Y1 - 1996/10
N2 - Hirschsprung disease (HSCR) is a congenital disorder associated with the absence of intrinsic ganglion cells in the distal gastrointestinal tract. Recently, many missense, nonsense and frameshift mutations of the ret proto-oncogene were found in familial and sporadic cases of HSCR. Consistent with the view that the HSCR phenotype is the result of inactivation of Ret, the missense mutations detected in the tyrosine kinase domain were demonstrated to result in a marked decrease of the kinase activity of Ret. However, the effects of missense mutations found in the extracellular domain remain unknown. We now report that five mutations in the extracellular domain examined inhibit transport of the Ret protein to the plasma membrane. As a consequence, they significantly decreased the transforming activity of Ret with multiple endocrine neoplasia (MEN) 2A mutation for which cell surface expression is required. Our results also demonstrated that long segment HSCR mutations more severely impair transport of Ret to the plasma membrane than a short segment HSCR mutation, suggesting that the level of its cell surface expression may correlate to the HSCR phenotype.
AB - Hirschsprung disease (HSCR) is a congenital disorder associated with the absence of intrinsic ganglion cells in the distal gastrointestinal tract. Recently, many missense, nonsense and frameshift mutations of the ret proto-oncogene were found in familial and sporadic cases of HSCR. Consistent with the view that the HSCR phenotype is the result of inactivation of Ret, the missense mutations detected in the tyrosine kinase domain were demonstrated to result in a marked decrease of the kinase activity of Ret. However, the effects of missense mutations found in the extracellular domain remain unknown. We now report that five mutations in the extracellular domain examined inhibit transport of the Ret protein to the plasma membrane. As a consequence, they significantly decreased the transforming activity of Ret with multiple endocrine neoplasia (MEN) 2A mutation for which cell surface expression is required. Our results also demonstrated that long segment HSCR mutations more severely impair transport of Ret to the plasma membrane than a short segment HSCR mutation, suggesting that the level of its cell surface expression may correlate to the HSCR phenotype.
UR - http://www.scopus.com/inward/record.url?scp=0029798406&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029798406&partnerID=8YFLogxK
U2 - 10.1093/hmg/5.10.1577
DO - 10.1093/hmg/5.10.1577
M3 - Article
C2 - 8894691
AN - SCOPUS:0029798406
SN - 0964-6906
VL - 5
SP - 1577
EP - 1580
JO - Human molecular genetics
JF - Human molecular genetics
IS - 10
ER -